10
Participants
Start Date
August 30, 2007
Primary Completion Date
February 28, 2008
Study Completion Date
February 28, 2008
insulin aspart
Treat-to-target dose titration scheme, injection s.c.
inhaled human insulin
Treat-to-target dose titration scheme, inhalation.
Novo Nordisk Investigational Site, Camperdown
Novo Nordisk Investigational Site, Broadmeadow
Novo Nordisk Investigational Site, Parkville
Novo Nordisk Investigational Site, Box Hill
Novo Nordisk Investigational Site, East Ringwood
Novo Nordisk Investigational Site, Kippa-Ring
Novo Nordisk Investigational Site, Auchenflower
Novo Nordisk Investigational Site, Keswick
Novo Nordisk Investigational Site, Pulau Pinang
Novo Nordisk Investigational Site, Belgrade
Novo Nordisk Investigational Site, Pittsburgh
Novo Nordisk Investigational Site, Kota Bharu, Kelantan
Novo Nordisk Investigational Site, Philadelphia
Novo Nordisk Investigational Site, Columbus
Novo Nordisk Investigational Site, Cheras
Novo Nordisk Investigational Site, Kansas City
Novo Nordisk Investigational Site, New Orleans
Novo Nordisk Investigational Site, Houston
Novo Nordisk Investigational Site, Ogden
Novo Nordisk Investigational Site, Fresno
Novo Nordisk Investigational Site, Spokane
Novo Nordisk Investigational Site, Chandigarh
Novo Nordisk Investigational Site, Pune
Novo Nordisk Investigational Site, Hyderabad
Novo Nordisk Investigational Site, Vellore
Novo Nordisk Investigational Site, Kolkata
Novo Nordisk Investigational Site, Mumbai
Novo Nordisk Investigational Site, Košice
Novo Nordisk Investigational Site, Ľubochňa
Novo Nordisk Investigational Site, Moldava nad Bodvou
Novo Nordisk Investigational Site, Žilina
Novo Nordisk Investigational Site, Žilina
Lead Sponsor
Novo Nordisk A/S
INDUSTRY